T. Rowe Price Associates’s Capricor Therapeutics CAPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$189K	Buy	19,018 +3,490	+22%	+$34.7K	﹤0.01%	2732
2025 Q1	$148K	Buy	15,528 +1,286	+9%	+$12.3K	﹤0.01%	2731
2024 Q4	$197K	Buy	+14,242	New	+$197K	﹤0.01%	2679